153.32
Charles River Laboratories International Inc (CRL) 最新ニュース
Charles River Laboratories Tops Q3 Estimates, Tightens Full-Year Outlook - MSN
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Charles River Deepens Cell Therapy Role And Expands AI Pathology Platform - simplywall.st
Charles River Laboratories International Inc. stock underperforms Friday when compared to competitors - MSN
Charles River (CRL) reliance on international sales: What investors need to know - MSN
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Director Nancy Andrews gifts Charles River (CRL) shares to trust - Stock Titan
Charles River Laboratories stock (US1591881009): Q1 earnings beat with updated FY guidance - AD HOC NEWS
Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions - BioSpace
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Charles River Laboratories stock (US1591881009): Shareholders approve 2026 incentive plan - AD HOC NEWS
Charles River (CRL) Partners with Medipost for Cell Therapy Adva - GuruFocus
Charles River Laboratories (CRL) Announces Approval of 2026 Long-Term Incentive Plan - GuruFocus
Director Steven Barg receives 1,438-share equity award at Charles River (NYSE: CRL) - Stock Titan
Charles River Labs (CRL) director receives 1,438-share equity award grant - Stock Titan
Director at Charles River (NYSE: CRL) receives 1,438-share stock grant - Stock Titan
Charles River Laboratories stock (US1591881009): Q1 earnings beat but FY2026 forecast cut - AD HOC NEWS
Number of shareholders of Charles River Laboratories International, Inc. – HAM:RV6 - TradingView
Charles River Laboratories International Inc (CRL) Stock Down 5. - GuruFocus
CRL Q1 Earnings & Revenues Top Estimates, Margins Crash, Stock Down - MSN
Charles River Labs Shareholders Approve New Incentive Plan - TipRanks
Charles River Laboratories International Inc. stock underperforms Monday when compared to competitors - MarketWatch
Charles River (NYSE: CRL) investors approve 2026 incentive plan, pay and auditor - Stock Titan
Charles River Laboratories International, Inc. Approves Ratification of PricewaterhouseCoopers LLP as Independent Auditors - marketscreener.com
Charles River (NYSE: CRL) director Abraham Ceesay receives 1,438-share stock grant - Stock Titan
Charles River Labs (NYSE: CRL) director Martin Mackay receives new stock grants - Stock Titan
Director at Charles River (NYSE: CRL) gets 1,438-share equity grant - Stock Titan
Charles River (NYSE: CRL) director receives stock grants instead of fees - Stock Titan
Director at Charles River (NYSE: CRL) receives 1,438-share stock award - Stock Titan
Director at Charles River (NYSE: CRL) receives 1,973-share equity award - Stock Titan
Director Virginia M. Wilson (CRL) receives 1,438-share equity award at Charles River - Stock Titan
Director James Foster gets 1,860 Charles River (NYSE: CRL) shares - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Charles River (CRL) Enhances Digital Pathology Platform for Fast - GuruFocus
Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow - 01net
Charles River (CRL) Reliance on International Sales: What Investors Need to Know - Yahoo Finance
Charles River expands AI-enabled digital pathology platform By Investing.com - Investing.com Canada
Charles River Laboratories stock (US1591881009): Core business and market position - AD HOC NEWS
Charles River Laboratories stock: Is CRL underperforming the healthcare sector? - MSN
Is It Time To Rethink Charles River Laboratories (CRL) After Its Recent Price Rebound? - Yahoo Finance
A Look At Charles River Laboratories (CRL) Valuation After Recent Share Price Momentum - simplywall.st
Charles River Laboratories International Q1 Earnings Call Highlights - Barchart.com
MSN Money - MSN
Charles River Laboratories stock (US1591881009): Shares dip after recent run-up as analysts eye upsi - AD HOC NEWS
Charles River Laboratories Q1 2026 earnings preview - MSN
These Analysts Increase Their Forecasts On Charles River After Better-Than-Expected Q1 Results - Benzinga
Charles River Laboratories International, Inc. Seeks M&A Opportunities - marketscreener.com
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2026 Earnings Call Transcript - Insider Monkey
Mizuho raises Charles River Labs stock price target on steady results - Investing.com Canada
Charles River: Q1 Earnings Snapshot - theheraldreview.com
Charles River Laboratories Q1 Adjusted Earnings Decline, Revenue Rises; Maintains 2026 Earnings Guidance - Moomoo
Johnson Opportunity Fund's Charles River Laboratories International Inc(CRL) Holding History - GuruFocus
Charles River Laboratories Announces First-Quarter 2026 Results - BioSpace
大文字化:
|
ボリューム (24 時間):